v3.26.1
Other Current Liabilities (Tables)
 6 Months Ended
Jun. 30, 2026
Other Liabilities, Current [Abstract]  
Summary of Other Current Liabilities

 

 

As of

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Refundable deposit related to TJ Biopharma preferred shares sale(1)

 

$

7,533

 

 

$

7,316

 

Bridge Health acquisition cost(2)

 

 

537

 

 

 

1,864

 

Withholding and value added taxes

 

 

599

 

 

 

—

 

Incentive payment from depository bank

 

 

209

 

 

 

—

 

Total other current liabilities

 

$

8,878

 

 

$

9,180

 
(1)
In September 2025, the Group entered into an agreement with TJ Biopharma to facilitate the sale of the Group’s holding of TJ Biopharma’s preferred shares, whereby TJ Biopharma paid the Group a cash deposit. See the Company’s Annual Report for additional information.
(2)
Represents the current portion of the non-contingent quarterly payments related to the Bridge Health acquisition. See Note 4 – Asset Acquisitions and Strategic Transactions for additional information.